Biological activity, quantitative structure–activity relationship analysis, and molecular docking of xanthone derivatives as anticancer drugs

Biological activity, quantitative structure–activity relationship analysis, and molecular docking of xanthone derivatives as anticancer drugs

Isnatin Miladiyah,1,2 Jumina Jumina,3 Sofia Mubarika Haryana,4 Mustofa Mustofa5 1Pharmacology Department, Faculty of Medicine, Islamic University of Indonesia, 2Doctorate Program of Medical Science and Health, Faculty of Medicine, 3Chemistry Department, Faculty of Mathematics and Natural Sciences,...

Full description

Bibliographic Details
Main Authors:	Miladiyah I, Jumina J, Haryana SM, Mustofa M
Format:	Article
Language:	English
Published:	Dove Medical Press 2018-01-01
Series:	Drug Design, Development and Therapy
Subjects:	Xanthones Anticancer Semi-empirical AM1 BuildQSAR Molecular docking
Online Access:	https://www.dovepress.com/biological-activity-quantitative-structure-activity-relationship-analy-peer-reviewed-article-DDDT

Similar Items

Quantitative Structure-Activity Relationship Analysis of Xanthone Derivates as Cytotoxic Agents in Liver Cancer Cell Line HepG2
by: Isnatin Miladiyah, et al.
Published: (2016-05-01)

Quantitative structure–activity relationship (QSAR) and molecular docking of xanthone derivatives as anti-tuberculosis agents
by: Emmy Yuanita, et al.
Published: (2020-12-01)

Molecular Docking and Molecular Dynamic Investigations of Xanthone-Chalcone Derivatives against Epidermal Growth Factor Receptor for Preliminary Discovery of Novel Anticancer Agent
by: Yehezkiel Steven Kurniawan, et al.
Published: (2024-02-01)

Structure–Activity Relationship of Xanthones as Inhibitors of Xanthine Oxidase
by: Ling-Yun Zhou, et al.
Published: (2018-02-01)

An Update on the Anticancer Activity of Xanthone Derivatives: A Review
by: Yehezkiel Steven Kurniawan, et al.
Published: (2021-11-01)

Chiral Derivatives of Xanthones with Antimicrobial Activity
by: Joana Araújo, et al.
Published: (2019-01-01)

Potential Of Mangosteen Xanthones As Anti-Oral Cancer Agents By Induction Of Apoptosis
by: Yani Corvianindya Rahayu
Published: (2012-07-01)

One-pot two-component synthesis of halogenated xanthone, 3-o substituted xanthone, and prenylated xanthone derivatives as aromatase inhibitors
by: Shurutishria Ramakrishnan, et al.
Published: (2023-01-01)

Synthesis, Cytotoxicity Evaluation and Molecular Docking Studies of Xanthyl-Cinnamate Derivatives as Potential Anticancer Agents
by: Muthia Rahayu Iresha, et al.
Published: (2022-09-01)

Molecular Docking and Multivariate Analysis of Xanthones as Antimicrobial and Antiviral Agents
by: Freddy A. Bernal, et al.
Published: (2015-07-01)

Quantitative Structure-Activity Relationship of 3-Thiocyanate-1H-Indoles Derived Compounds as Antileukemia by AM1, PM3, and RM1 Methods
by: Ponco Iswanto, et al.
Published: (2023-05-01)

Synthesis and biological evaluation of novel benzo[b]xanthone derivatives as potential antitumor agents
by: Luo Lin, et al.
Published: (2013-01-01)

Enantiomeric Resolution and Docking Studies of Chiral Xanthonic Derivatives on Chirobiotic Columns
by: Ye‛ Zaw Phyo, et al.
Published: (2018-01-01)

Synthesis, characterization and molecular docking of hydroxyxanthone and renylated xanthone derivatives as potential aromatase inhibitor
by: Ramakrishnan, Shurutishria
Published: (2022)

A Computational QSAR, Molecular Docking and In Vitro Cytotoxicity Study of Novel Thiouracil-Based Drugs with Anticancer Activity against Human-DNA Topoisomerase II
by: Doaa M. Khaled, et al.
Published: (2022-10-01)

Structural diversity and biological activities of caged Garcinia xanthones: recent updates
by: Yee Lin Phang, et al.
Published: (2022-02-01)

Naturally occurring pentaoxygenated, hexaoxygenated and dimeric xanthones: a literature survey
by: V. Peres, et al.
Published: (1997-08-01)

Design and docking of novel series of hybrid xanthones as anti-cancer agent to target human DNA topoisomerase 2-alpha
by: Lalit Mohan Nainwal, et al.
Published: (2014-05-01)

Xanthone studies III: Synthesis of some hydroxy and methoxy substituted xanthones /
by: Arends, Peter, et al.

Marine-Derived Xanthone from 2010 to 2021: Isolation, Bioactivities and Total Synthesis
by: Ana C. S. Veríssimo, et al.
Published: (2022-05-01)

Xanthone Derivatives in the Fight against Glioblastoma and Other Cancers
by: Gabriela Mazur, et al.
Published: (2023-02-01)

Synthetic dimethoxyxanthones bind similarly to human serum albumin compared with highly oxygenated xanthones
by: Otávio Augusto Chaves, et al.
Published: (2024-06-01)

Xanthones from garcinia eugenifolia / M.Taher, Muhammad Sum Idris, Dayar Arbain
by: 174651 M. Taher, et al.

PRENYLATED XANTHONES FROM Rheedia acuminata
by: Maria das G. B ZOGHBI, et al.
Published: (1993-01-01)

Extraction, physicochemical properties and antioxidant activities of xanthone from mangosteen (Garcinia mangostana Linn.) pericarp
by: Aboutorab, Nasrin
Published: (2017)

Synthesis and Molecular Docking Studies of Alkoxy- and Imidazole-Substituted Xanthones as α-Amylase and α-Glucosidase Inhibitors
by: Dolores G. Aguila-Muñoz, et al.
Published: (2023-05-01)

Antiprotozoal Activity of Xanthone Derivatives
by: Ana Camila Micheletti, et al.
Published: (2020-09-01)

Antiprotozoal Activity of Xanthone Derivatives
by: Ana Camila Micheletti, et al.
Published: (2020-09-01)

Quantitative structure–activity relationship modeling and docking of some synthesized bioactive oxopyrolidines against Staphylococcus aureus
by: Mohammed Albratty
Published: (2022-07-01)

In vitro evaluation, in silico studies and toxicological assay of some xanthones as potential Leishmania donovani inhibitors
by: Marwa S. Osman, et al.
Published: (2022-01-01)

Chiral Derivatives of Xanthones: Investigation of the Effect of Enantioselectivity on Inhibition of Cyclooxygenases (COX-1 and COX-2) and Binding Interaction with Human Serum Albumin
by: Carla Fernandes, et al.
Published: (2017-05-01)

Machine Learning Application for Medicinal Chemistry: Colchicine Case, New Structures, and Anticancer Activity Prediction
by: Damian Nowak, et al.
Published: (2024-01-01)

Evaluation of the Antioxidant, Antidiabetic, and Antiplasmodial Activities of Xanthones Isolated from <i>Garcinia forbesii</i> and Their <i>In Silico</i> Studies
by: Johanis Wairata, et al.
Published: (2021-10-01)

Anticancer activity and QSAR study of sulfur-containing thiourea and sulfonamide derivatives
by: Ratchanok Pingaew, et al.
Published: (2022-08-01)

Extractives from Guttiferae : Part XIV, The structures of seven xanthones from the heartwood of Mammea africana L /
by: 425298 Carpenter, I., et al.

QSAR, Molecular Docking, MD Simulation and MMGBSA Calculations Approaches to Recognize Concealed Pharmacophoric Features Requisite for the Optimization of ALK Tyrosine Kinase Inhibitors as Anticancer Leads
by: Rahul D. Jawarkar, et al.
Published: (2022-08-01)

QSAR Evaluations to Unravel the Structural Features in Lysine-Specific Histone Demethylase 1A Inhibitors for Novel Anticancer Lead Development Supported by Molecular Docking, MD Simulation and MMGBSA
by: Rahul D. Jawarkar, et al.
Published: (2022-07-01)

Isolation, Biosynthesis, and Biological Activity of Polycyclic Xanthones From Actinomycetes
by: Hui-Qing Yu, et al.
Published: (2022-07-01)

The Synthesis and Characterization of a Delivery System Based on Polymersomes and a Xanthone with Inhibitory Activity in Glioblastoma
by: Ana Alves, et al.
Published: (2024-01-01)

Potency of xanthone derivatives as antibacterial agent against Methicillin-Resistant Staphylococcus Aureus (MRSA)
by: Isnatin Miladiyah, et al.
Published: (2017-06-01)